Pain Management

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC3-5

DiraChart Clinical Reference
Protected section 5 of 12
← Document menu
Home Care · DiraChart

1. Purpose and disease relevance

DiraChart Clinical Reference

Section NavigationPart 5 of 12PreviousNext

4. Key visit elements — in addition to the Pain assessment

In addition to the full Pain assessment (location, quality, intensity, pattern, and the general pain evaluation documented there), the pain-management overlay adds each visit:

  • The pain score and, more importantly, its functional impact stated against the ordered goal — for example “pain 4/10, able to transfer and sleep, meeting the functional goal” — rather than “pain at baseline.”
  • The sedation score (on the ordered scale) and the respiratory rate — the opioid-safety vitals — recorded with the timing relative to opioid doses.
  • Naloxone presence and expiration and the caregiver’s ability to use it.
  • Bowel status against the ordered interval and the effect of the bowel regimen (cross-reference Gastrointestinal).
  • Opioid and adjuvant adherence, breakthrough-medication frequency against the ordered limit, and any request to escalate.
  • A safety screen for concurrent alcohol or sedating agents and for safe storage and handling — framed as harm prevention, not accusation.
  • Non-opioid and non-pharmacologic measures in use (positioning, heat or cold, activity, and adjuvant analgesics) and their effect.
  • The effect of pain and its treatment on mood, sleep, and function (cross-reference Cognitive/Mental Status).
Section NavigationPart 5 of 12PreviousNext